<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0376617</journal-id>
<journal-id journal-id-type="pubmed-jr-id">5462</journal-id>
<journal-id journal-id-type="nlm-ta">Lab Invest</journal-id>
<journal-id journal-id-type="iso-abbrev">Lab. Invest.</journal-id>
<journal-title-group>
<journal-title>Laboratory investigation; a journal of technical methods and pathology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0023-6837</issn>
<issn pub-type="epub">1530-0307</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28759008</article-id>
<article-id pub-id-type="pmc">5918271</article-id>
<article-id pub-id-type="doi">10.1038/labinvest.2017.81</article-id>
<article-id pub-id-type="manuscript">NIHMS959323</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A pathologist’s perspective on induced pluripotent stem cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Watanabe</surname>
<given-names>Noriko</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Santostefano</surname>
<given-names>Katherine E</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yachnis</surname>
<given-names>Anthony T</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Terada</surname>
<given-names>Naohiro</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, Gainesville, FL, USA</aff>
<aff id="A2">
<label>2</label>Center for Cellular Reprogramming, University of Florida College of Medicine, Gainesville, FL, USA</aff>
<author-notes>
<corresp id="FN1">Correspondence: Dr N Terada, MD, PhD, Department of Pathology, Immunology and Laboratory Medicine, Center for Cellular Reprogramming, University of Florida College of Medicine, PO Box 100275, Gainesville, FL 32610, USA. <email>terada@pathology.ufl.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p>
<bold>DISCLOSURE/CONFLICT OF INTEREST</bold>
</p>
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>13</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>31</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>26</day>
<month>4</month>
<year>2018</year>
</pub-date>
<volume>97</volume>
<issue>10</issue>
<fpage>1126</fpage>
<lpage>1132</lpage>
<!--elocation-id from pubmed: 10.1038/labinvest.2017.81-->
<abstract>
<p id="P1">Induced pluripotent stem cell (iPSC) technology was originally developed in 2006. Essentially, it converts somatic cells into pluripotent stem cells by transiently expressing a few transcriptional factors. Once generated, these iPSCs can differentiate into all the cell types of our body, theoretically, which has attracted great attention for clinical research including disease pathobiology studies. Could this technology then become an additional research or diagnostic tool widely available to practicing pathologists? Here we summarize progress in iPSC research toward disease pathobiology studies, its future potential, and remaining problems from a pathologist’s perspective. A particular focus will be on introducing the effort to recapitulate disease-related morphological changes through three-dimensional culture of stem cells such as organoid differentiation.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>